NEULAND LAB (NEULANDLAB)
companyActive threads
Neuland Laboratories Q2 profit falls 47% as capex squeezes margins
Neuland Laboratories Q2: Profit falls 47%, revenue declines 12.5%; margins contract - Published OnNov 3, 2026 | 16:54 IST - Last Updated OnNov 3, 2026 | 16:54 IST Heavy capital investments in research facilities and peptide manufacturing units squeezed profitability during the quarter, even as overall capacity expansion efforts pressed ahead. Discover which commercial molecules are expected to drive near-term recovery.
Neuland Laboratories Q2 margins contract to 24.1% as revenue falls
Neuland Laboratories shares in focus after Q2 results see revenue drop and margin contraction - Published OnNov 4, 2026 | 07:30 IST - Last Updated OnNov 4, 2026 | 07:30 IST Neuland Laboratories' margins in the September quarter contracted to 24.1% from 30.2% in the year-ago period and from 34.7% in the prior quarter. Shares of Neuland Laboratories Ltd. are in focus on Wednesday, November 4, after the company reported a volatile set of numbers for the second quarter after market hours on Tuesday.
Vijay Kedia portfolio adds one stock, five surge 55%
Investors often track the portfolios of seasoned market veterans for insights into their investment strategies. In this context, ETMarkets reviewed the investment holdings of veteran investor Vijay Kedia. According to the latest available data for the June 2026 quarter, Kedia has publicly disclosed stakes in around 23 companies, with a combined market value of approximately Rs 1,415 crore as of August 21.
Intelligence feed· 1 article in 1440m
Neuland Laboratories shares in focus after Q2 results see revenue drop and margin contraction - CNBC TV18
Story first reported.